OXiGENE is led by a talented team of business, medical, and drug development / discovery professionals with extensive biopharmaceutical industry experience.

Peter J. Langecker, MD, Ph.D
Chief Executive Officer, Chairman

Barbara Riching, CPA
Chief Financial Officer

Jai Balkissoon, MD
Senior Clinical Research Consultant

Kathleen M. Lee, MBA, Ph.D
Vice President, CMC (Chemistry, Manufacturing and Controls)

Alice M. Varga, MS, MA
Vice President, Regulatory and Quality Assurance

Ravi Kaiwar, MBA, Ph.D
Business Development Consultant